Kyverna Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2024 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Kyverna Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2024 to Q3 2024.
  • Kyverna Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2024 was $903K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $903K Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.09M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.34M Mar 31, 2024 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.